Pyruvate kinase deficiency in France: a 3-year study reveals 27 new mutations
- PMID:16704447
- DOI: 10.1111/j.1365-2141.2006.06076.x
Pyruvate kinase deficiency in France: a 3-year study reveals 27 new mutations
Abstract
Pyruvate kinase (PK) deficiency is the most common enzyme defect affecting the glycolytic pathway of the erythrocyte. Usually, it is clinically silent in heterozygotes but serious disorders are described at birth in homozygotes or compound heterozygotes. Including the mutants herein reported, more than 180 mutations of the PK-LR gene have now been identified. This 3-year study was carried out to detect mutations associated with disease-affecting families. Haematological indices, erythrocyte PK and glucose-6-phosphate dehydrogenase activities were measured. Molecular characterisation of the PK gene mutations included restriction enzyme analysis, mutation scanning and gene sequencing. Among the 56 families studied, nine homozygous cases and 41 different mutations were found. Eight mutations involved a splice site, 31 missense mutations were located in crucial domains of the molecule (catalytic site, cleft between the A and C domains, A/A' interface) and two cases of insertion-deletion were found. In total, 20 new mutations modifying the structure of the enzyme and seven affecting a splice site are reported. PK deficiency is an under diagnosed disease. However, deficiency could be life threatening in perinatal period and we report two lethal cases. These results support the characterisation of PK mutations, and show that prenatal diagnosis can identify affected infants and prepare safer conditions for the birth.
Comment in
- Molecular characterisation of pyruvate kinase deficiency--concerns about the description of mutant PKLR alleles.van Wijk R, Rijksen G, van Solinge WW.van Wijk R, et al.Br J Haematol. 2007 Jan;136(1):167-9; author reply 169-70. doi: 10.1111/j.1365-2141.2006.06399.x.Br J Haematol. 2007.PMID:17222205No abstract available.
Similar articles
- Red cell pyruvate kinase deficiency: 17 new mutations of the PK-LR gene.Fermo E, Bianchi P, Chiarelli LR, Cotton F, Vercellati C, Writzl K, Baker K, Hann I, Rodwell R, Valentini G, Zanella A.Fermo E, et al.Br J Haematol. 2005 Jun;129(6):839-46. doi: 10.1111/j.1365-2141.2005.05520.x.Br J Haematol. 2005.PMID:15953013
- Pyruvate kinase deficiency: the genotype-phenotype association.Zanella A, Fermo E, Bianchi P, Chiarelli LR, Valentini G.Zanella A, et al.Blood Rev. 2007 Jul;21(4):217-31. doi: 10.1016/j.blre.2007.01.001. Epub 2007 Mar 13.Blood Rev. 2007.PMID:17360088Review.
- Red cell enzymopathies as a model of inborn errors of metabolism.Miwa S, Kanno H, Hirono A, Fujii H.Miwa S, et al.Southeast Asian J Trop Med Public Health. 1995;26 Suppl 1:112-9.Southeast Asian J Trop Med Public Health. 1995.PMID:8629088Review.
- Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: tabulation of mutant enzymes.Miwa S, Fujii H.Miwa S, et al.Am J Hematol. 1996 Feb;51(2):122-32. doi: 10.1002/(SICI)1096-8652(199602)51:2<122::AID-AJH5>3.0.CO;2-#.Am J Hematol. 1996.PMID:8579052Review.
- Fifteen novel mutations in PKLR associated with pyruvate kinase (PK) deficiency: structural implications of amino acid substitutions in PK.van Wijk R, Huizinga EG, van Wesel AC, van Oirschot BA, Hadders MA, van Solinge WW.van Wijk R, et al.Hum Mutat. 2009 Mar;30(3):446-53. doi: 10.1002/humu.20915.Hum Mutat. 2009.PMID:19085939
Cited by
- Molecular heterogeneity of pyruvate kinase deficiency.Bianchi P, Fermo E.Bianchi P, et al.Haematologica. 2020 Sep 1;105(9):2218-2228. doi: 10.3324/haematol.2019.241141.Haematologica. 2020.PMID:33054047Free PMC article.Review.
- Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency.Garcia-Gomez M, Calabria A, Garcia-Bravo M, Benedicenti F, Kosinski P, López-Manzaneda S, Hill C, Del Mar Mañu-Pereira M, Martín MA, Orman I, Vives-Corrons JL, Kung C, Schambach A, Jin S, Bueren JA, Montini E, Navarro S, Segovia JC.Garcia-Gomez M, et al.Mol Ther. 2016 Aug;24(7):1187-98. doi: 10.1038/mt.2016.87. Epub 2016 May 3.Mol Ther. 2016.PMID:27138040Free PMC article.
- Erythrocytic pyruvate kinase mutations causing hemolytic anemia, osteosclerosis, and secondary hemochromatosis in dogs.Gultekin GI, Raj K, Foureman P, Lehman S, Manhart K, Abdulmalik O, Giger U.Gultekin GI, et al.J Vet Intern Med. 2012 Jul-Aug;26(4):935-44. doi: 10.1111/j.1939-1676.2012.00958.x.J Vet Intern Med. 2012.PMID:22805166Free PMC article.
- Erythrocyte disorders in the perinatal period.Steiner LA, Gallagher PG.Steiner LA, et al.Semin Perinatol. 2007 Aug;31(4):254-61. doi: 10.1053/j.semperi.2007.05.003.Semin Perinatol. 2007.PMID:17825683Free PMC article.Review.
- NovelPKLR missense mutation (A300P) causing pyruvate kinase deficiency in an Omani Kindred-PK deficiency masquerading as congenital dyserythropoietic anemia.Fawaz N, Beshlawi I, Alqasim A, Zachariah M, Russo R, Andolfo I, Gambale A, Pathare A, Iolascon A.Fawaz N, et al.Clin Case Rep. 2022 Feb 7;10(2):e05315. doi: 10.1002/ccr3.5315. eCollection 2022 Feb.Clin Case Rep. 2022.PMID:35154711Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources